The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | |||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | ||||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | FIGI | (to the nearest dollar) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| ALTAIR ENGR INC | COM CL A | 021369103 | 1,356,237,300 | 12,430,000 | SH | SOLE | 12,430,000 | 0 | 0 | |||
| AURA BIOSCIENCES INC | COM | 05153U107 | 56,905,991 | 6,922,870 | SH | SOLE | 6,922,870 | 0 | 0 | |||
| GLOBALFOUNDRIES INC | ORDINARY SHARES | G39387108 | 612,109,090 | 14,264,952 | SH | SOLE | 14,264,952 | 0 | 0 | |||
| PERIMETER SOLUTIONS INC | COMMON STOCK | 71385M107 | 83,760,120 | 6,554,000 | SH | SOLE | 6,554,000 | 0 | 0 | |||
| ZENTALIS PHARMACEUTICALS INC | COM | 98943L107 | 42,298,718 | 13,959,973 | SH | SOLE | 13,959,973 | 0 | 0 | |||